Association of P62/SQSTM1 Excess and Oral Carcinogenesis

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2013 Oct 3

PMID 24086340

Citations 25

Authors

Takuma Inui

Tokuhiro Chano

Mikiko Takikita-Suzuki

Masanori Nishikawa

Gaku Yamamoto

Hidetoshi Okabe

Affiliations

Soon will be listed here.

Abstract

p62/SQSTM1 (sequestosome1) has never been evaluated in oral epithelium. In order to clarify the role of p62/SQSTM1 in carcinogenesis in oral epithelium, both p62/SQSTM1 and Nrf2 were immunohistochemically evaluated in 54 carcinomas and 14 low grade dysplasias. p62/SQSTM1 knockdowns were also designed in oral cancer cells, and we analyzed the Nrf2 pathway, GSH contents and ROS accumulation. The association between p62/SQSTM1 excess and prognosis was addressed in a clinical cohort of oral carcinoma cases. p62/SQSTM1 excess was more obvious in carcinomas, but Nrf2 was abundant in almost all samples of the oral epithelium. In oral carcinoma cells, p62/SQSTM1 knockdown did not affect the Nrf2-Keap1 pathway but did significantly reduce GSH content with subsequent ROS accumulation, and caused cell growth inhibition in the irradiated condition. Finally, p62/SQSTM1 excess was associated with poor prognosis in a clinical cohort. In oral epithelial carcinogenesis, p62/SQSTM1 excess played a role in GSH induction rather than Nrf2 accumulation, and may cause resistance to cytotoxic stresses such as radiation or chemotherapy. Immunohistochemical evaluation of p62/SQSTM1 may be a potential significant marker to identify early carcinogenesis, chemo-radiotherapeutic resistance or poor prognosis of oral squamous cell carcinomas.

Citing Articles

p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Yang X, Cao X, Zhu Q Cancer Metastasis Rev. 2025; 44(1):33.

PMID: 39954143 PMC: 11829845. DOI: 10.1007/s10555-025-10250-w.

SQSTM1/p62 predicts prognosis and upregulates the transcription of CCND1 to promote proliferation in mantle cell lymphoma.

Zhang S, Huang F, Wang J, You R, Huang Q, Chen Y Protoplasma. 2025; .

PMID: 39786615 DOI: 10.1007/s00709-024-02023-z.

PI3K/AKT Signaling Pathway Mediated Autophagy in Oral Carcinoma - A Comprehensive Review.

Rajendran P, Sekar R, Dhayasankar P, Ali E, Abdelsalam S, Balaraman S Int J Med Sci. 2024; 21(6):1165-1175.

PMID: 38774756 PMC: 11103401. DOI: 10.7150/ijms.94566.

Autophagy and nuclear morphometry are associated with histopathologic features in esophageal squamous cell carcinoma.

Iserhard R, Pilar E, de Oliveira F, Callegari-Jacques S, Ferst P, Visioli F J Mol Med (Berl). 2023; 102(1):39-52.

PMID: 37878028 DOI: 10.1007/s00109-023-02387-4.

The sequestosome 1 protein: therapeutic vulnerabilities in ovarian cancer.

Nurzadeh M, Ghalandarpoor-Attar S, Ghalandarpoor-Attar S, Rabiei M Clin Transl Oncol. 2023; 25(10):2783-2792.

PMID: 36964889 DOI: 10.1007/s12094-023-03148-y.

References

Arai A, Chano T, Futami K, Furuichi Y, Ikebuchi K, Inui T . RECQL1 and WRN proteins are potential therapeutic targets in head and neck squamous cell carcinoma. Cancer Res. 2011; 71(13):4598-607. DOI: 10.1158/0008-5472.CAN-11-0320. View

Holtzclaw W, Dinkova-Kostova A, Talalay P . Protection against electrophile and oxidative stress by induction of phase 2 genes: the quest for the elusive sensor that responds to inducers. Adv Enzyme Regul. 2004; 44:335-67. DOI: 10.1016/j.advenzreg.2003.11.013. View

Su Y, Qian H, Zhang J, Wang S, Shi P, Peng X . The diversity expression of p62 in digestive system cancers. Clin Immunol. 2005; 116(2):118-23. DOI: 10.1016/j.clim.2005.04.004. View

Salzman R, Pacal L, Kankova K, Tomandl J, Horakova Z, Tothova E . High perioperative level of oxidative stress as a prognostic tool for identifying patients with a high risk of recurrence of head and neck squamous cell carcinoma. Int J Clin Oncol. 2010; 15(6):565-70. DOI: 10.1007/s10147-010-0108-z. View

Biswas S, Rahman I . Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med. 2008; 30(1-2):60-76. PMC: 2699458. DOI: 10.1016/j.mam.2008.07.001. View

Zhang J, Chan E, Peng X, Tan E . A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med. 1999; 189(7):1101-10. PMC: 2193003. DOI: 10.1084/jem.189.7.1101. View

Zieba A, Wahlby C, Hjelm F, Jordan L, Berg J, Landegren U . Bright-field microscopy visualization of proteins and protein complexes by in situ proximity ligation with peroxidase detection. Clin Chem. 2009; 56(1):99-110. DOI: 10.1373/clinchem.2009.134452. View

Inoue D, Suzuki T, Mitsuishi Y, Miki Y, Suzuki S, Sugawara S . Accumulation of p62/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci. 2012; 103(4):760-6. PMC: 7659245. DOI: 10.1111/j.1349-7006.2012.02216.x. View

Furukawa M, Xiong Y . BTB protein Keap1 targets antioxidant transcription factor Nrf2 for ubiquitination by the Cullin 3-Roc1 ligase. Mol Cell Biol. 2004; 25(1):162-71. PMC: 538799. DOI: 10.1128/MCB.25.1.162-171.2005. View

10.

Forman H, Dickinson D . Oxidative signaling and glutathione synthesis. Biofactors. 2003; 17(1-4):1-12. DOI: 10.1002/biof.5520170101. View

11.

Kobayashi M, Yamamoto M . Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul. 2006; 46:113-40. DOI: 10.1016/j.advenzreg.2006.01.007. View

12.

Bui C, Shin J . Persistent expression of Nqo1 by p62-mediated Nrf2 activation facilitates p53-dependent mitotic catastrophe. Biochem Biophys Res Commun. 2011; 412(2):347-52. DOI: 10.1016/j.bbrc.2011.07.101. View

13.

Kobayashi A, Kang M, Okawa H, Ohtsuji M, Zenke Y, Chiba T . Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol. 2004; 24(16):7130-9. PMC: 479737. DOI: 10.1128/MCB.24.16.7130-7139.2004. View

14.

Zhang D, Lo S, Cross J, Templeton D, Hannink M . Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004; 24(24):10941-53. PMC: 533977. DOI: 10.1128/MCB.24.24.10941-10953.2004. View

15.

Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K, Jarvius J . Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3(12):995-1000. DOI: 10.1038/nmeth947. View

16.

Bohn S, Smeland S, Sakhi A, Thoresen M, Russnes K, Tausjo J . Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett. 2005; 238(2):240-7. DOI: 10.1016/j.canlet.2005.07.027. View

17.

Wakabayashi N, Itoh K, Wakabayashi J, Motohashi H, Noda S, Takahashi S . Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat Genet. 2003; 35(3):238-45. DOI: 10.1038/ng1248. View

18.

Komatsu M, Kurokawa H, Waguri S, Taguchi K, Kobayashi A, Ichimura Y . The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol. 2010; 12(3):213-23. DOI: 10.1038/ncb2021. View

19.

Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y . An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun. 1997; 236(2):313-22. DOI: 10.1006/bbrc.1997.6943. View

20.

Dinkova-Kostova A, Holtzclaw W, Cole R, Itoh K, Wakabayashi N, Katoh Y . Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci U S A. 2002; 99(18):11908-13. PMC: 129367. DOI: 10.1073/pnas.172398899. View